Lithium Americas Corp vs Medpace Holdings Inc — how do they compare? Lithium Americas Corp trades at $3.07 (market cap $1.01B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Medpace Holdings Inc is far larger — about 14.9× Lithium Americas Corp's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| LAC | MEDP | |
|---|---|---|
Market Cap | $1.01B | $15.08B |
Sector | Basic Materials | Technology |
52-Week High | $10.05 | $620.59 |
52-Week Low | $2.55 | $308.88 |
Enterprise Value | $1.13B | $14.55B |
Trailing returns across standard periods
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →